Clinical effectiveness and cost-consequences of selective serotonin reuptake inhibitors in the treatment of sex offenders.
Adi
Y
Y
West Midlands Health Technology Assessment Collaboration, Department of Public Health and Epidemiology, University of Birmingham, UK.
Ashcroft
D
D
Browne
K
K
Beech
A
A
Fry-Smith
A
A
Hyde
C
C
D000726:Androgen Antagonists / Q000191:economics / Q000627:therapeutic use; D003362:Cost-Benefit Analysis; D017373:Cyproterone Acetate / Q000191:economics / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008297:Male; D017367:Selective Serotonin Reuptake Inhibitors / Q000191:economics / Q000627:therapeutic use; D012742:Sex Offenses; D016896:Treatment Outcome
D000726:Androgen Antagonists; D017373:Cyproterone Acetate; D017367:Selective Serotonin Reuptake Inhibitors